- Home
- IQI vs SOPH Comparison
IQI vs SOPH Comparison
Compare IQI & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IQI | SOPH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.1M | 462.3M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IQI | SOPH |
|---|---|---|
| Price | $9.07 | $7.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.75 |
| AVG Volume (30 Days) | 274.5K | ★ 557.6K |
| Earning Date | 01-01-0001 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.24 |
| Revenue Next Year | N/A | $24.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.47 | $3.83 |
| 52 Week High | $10.42 | $8.98 |
Technical Indicators
Market Signals| Indicator | IQI | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 50.34 |
| Support Level | $8.81 | $4.58 |
| Resistance Level | $9.95 | $7.88 |
| Average True Range (ATR) | 0.15 | 0.44 |
| MACD | 0.05 | 0.10 |
| Stochastic Oscillator | 78.26 | 71.47 |
Price Performance
Historical ComparisonAbout IQI Invesco Quality Municipal Income Trust
Invesco Quality Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide current income which is exempt from federal income tax.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.